Evidence map›Paper›PMID 37596278›Full record

ArticleNature communications2023

An idiosyncratic zonated stroma encapsulates desmoplastic liver metastases and originates from injured liver.

Carlos Fernández Moro, Natalie Geyer, Sara Harrizi, Yousra Hamidi, Sara Söderqvist, Danyil Kuznyecov, Evelina Tidholm Qvist, Media Salmonson Schaad, Laura Hermann, Amanda Lindberg and 16 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 6 institutions in 3 countries.

Carlos Fernández Moro *Department of Biosciences and Nutrition, Karolinska Institutet, 14183, Huddinge, Sweden.ORCID http://orcid.org/0000-0001-6863-5959
Natalie Geyer *Department of Biosciences and Nutrition, Karolinska Institutet, 14183, Huddinge, Sweden.
Sara Harrizi *Department of Biosciences and Nutrition, Karolinska Institutet, 14183, Huddinge, Sweden.
Yousra Hamidi *Department of Biosciences and Nutrition, Karolinska Institutet, 14183, Huddinge, Sweden.
Sara SöderqvistDepartment of Biosciences and Nutrition, Karolinska Institutet, 14183, Huddinge, Sweden.
Danyil KuznyecovDepartment of Clinical Genetics, Pathology and Molecular Diagnostics, Medicinsk Service, Skåne University Hospital, 22185, Lund, Sweden.ORCID http://orcid.org/0009-0007-8218-557X
Evelina Tidholm QvistDepartment of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, 14186, Sweden.
Media Salmonson SchaadDepartment of Biosciences and Nutrition, Karolinska Institutet, 14183, Huddinge, Sweden.
Laura HermannDepartment of Biosciences and Nutrition, Karolinska Institutet, 14183, Huddinge, Sweden.
Amanda LindbergDepartment of Immunology, Genetics and Pathology, Uppsala University, 75185, Uppsala, Sweden.
Rainer L HeuchelPancreatic Cancer Research Laboratory, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 14183, Hudinge, Sweden.ORCID http://orcid.org/0000-0002-2782-585X
Alfonso Martín-BernabéDepartment of Oncology-Pathology, Karolinska Institutet, 17176, Solna, Sweden.
Soniya DhanjalCRISPR Functional Genomics, SciLifeLab and Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 17165, Solna, Sweden.
Anna C NavisCRISPR Functional Genomics, SciLifeLab and Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 17165, Solna, Sweden.ORCID http://orcid.org/0000-0002-5267-4678
Christina VillardDepartment of Medicine Huddinge, Karolinska Institutet, 14183, Huddinge, Sweden.
Andrea C Del ValleDepartment of Biosciences and Nutrition, Karolinska Institutet, 14183, Huddinge, Sweden.ORCID http://orcid.org/0000-0002-1698-9533
Lorand BozókyDepartment of Biosciences and Nutrition, Karolinska Institutet, 14183, Huddinge, Sweden.
Ernesto SparrelidDepartment of Clinical Science, Intervention and Technology, Division of Surgery, Karolinska Institutet, Karolinska University Hospital, 14152, Stockholm, Sweden.
Luc DirixTranslational Cancer Research Unit (GZA Hospitals and University of Antwerp), Antwerp, Belgium.ORCID http://orcid.org/0000-0002-6248-1677
Carina StrellDepartment of Immunology, Genetics and Pathology, Uppsala University, 75185, Uppsala, Sweden.
Arne ÖstmanDepartment of Oncology-Pathology, Karolinska Institutet, 17176, Solna, Sweden.ORCID http://orcid.org/0000-0003-3993-0021
Bernhard SchmiererCRISPR Functional Genomics, SciLifeLab and Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 17165, Solna, Sweden.ORCID http://orcid.org/0000-0002-9082-7022
Peter B VermeulenTranslational Cancer Research Unit (GZA Hospitals and University of Antwerp), Antwerp, Belgium.
Jennie EngstrandDepartment of Clinical Science, Intervention and Technology, Division of Surgery, Karolinska Institutet, Karolinska University Hospital, 14152, Stockholm, Sweden.ORCID http://orcid.org/0000-0003-1123-7022
Béla BozókyDepartment of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, 14186, Sweden.
Marco GerlingDepartment of Biosciences and Nutrition, Karolinska Institutet, 14183, Huddinge, Sweden. marco.gerling@ki.se.ORCID http://orcid.org/0000-0002-1810-0662
Karolinska Institutet · SEKarolinska University Hospital · SEScience for Life Laboratory · SEUniversity of Antwerp · BEUppsala University · SESkåne University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A perimetastatic capsule is a strong positive prognostic factor in liver metastases, but its origin remains unclear. Here, we systematically quantify the capsule's extent and cellular composition in 263 patients with colorectal cancer liver metastases to investigate its clinical significance and origin. We show that survival improves proportionally with increasing encapsulation and decreasing tumor-hepatocyte contact. Immunostaining reveals the gradual zonation of the capsule, transitioning from benign-like NGFR

Indexed as

Liver NeoplasmsAnimalsClinical RelevanceHepatocytesMice

Identifiers

PMID37596278
PMCPMC10439160
OpenAlexW4385986833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.